![20230127_070358 20230127_070358](https://farmasi.unpad.ac.id/wp-content/uploads/2020/12/20230127_070358-200x200.jpg)
Dr. apt. Dian Ayu Eka Pitaloka, M.Si
![]() |
![]() |
SHORT BIOGRAPHY
- Name : Dian Ayu Eka Pitaloka
- Born in : Jember, January 11, 1993
- Nationality : Indonesian
- Gender : Female
- Job Title : Lecturer/researcher
- Work Place : Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran – Indonesia
- Email : pitaloka@unpad.ac.id
EDUCATIONAL BACKGROUND
Degree | Year | University |
Bachelor | 2010 – 2014 | Universitas Jember – Indonesia |
Professional (Pharmacist) | 2014 – 2015 | Institut Teknologi Bandung – Indonesia |
Master | 2015 – 2017 | Institut Teknologi Bandung – Indonesia |
PhD | 2017 – 2020 | Institut Teknologi Bandung – Indonesia |
RESEARCH INTEREST
Biomedical data science and bioinformatics of infectious diseases, with a focus on biomarker findings in tuberculosis.
RESEARCH EXPERIENCE
Year | Research Title | Program |
2023 | Exploration of the Inhibition of Triterpenoid and Limonoid Compounds Against Mycobacterium Tuberculosis using the Microscopic Observation Drug Susceptibility (MODS) Method | UNPAD internal research grant |
2023 | Cell-based biosensor for diagnosis of urine mycobacteria lipoarabinomannan: recent advancement and challenges | UNPAD internal research grant |
2023 | In silico study of triterpenoid and limonoid derivatives as enoyl acyl carrier protein reductase (inha) enzyme inhibitors of Mycobacterium tuberculosis | UNPAD internal research grant |
2022 | Determination of critical concentrations of second-line antituberculosis drugs for Mycobacterium tuberculosis susceptibility testing using the MycoTB sensititre | UNPAD internal research grant |
2017 | Antituberculosis action of ursolic acid and its regulation in C57BL/6 mouse bone marrow macrophages infectd with Mycobacterium avium | Dikti-funded research grant |
RESEARCH PUBLICATION
Scopus ID: 571938483000 (h-index 7, total citations of 110 by 103 documents, per December, 2023)
Year | Document Title | Journal |
2023 | Development and validation of assessment instrument for the perception and attitude toward tuberculosis among the general population in Indonesia: a Rasch analysis of psychometric properties | Frontiers in Public Health, 2023, 11, 1143120 |
2023 | Discovery of potent triterpenoid and limonoid compounds targeting Mycobacterium tuberculosis enoyl acyl carrier protein reductase (InhA): An in silico investigation | Informatics in Medicine Unlocked, 2023, 40, 101299 |
2023 | Insights from the molecular mechanism of pyrazinamide to mutated pyrazinamidase linked to the pncA gene in clinical isolates of Mycobacterium tuberculosis | Journal of Biomolecular Structure and Dynamics, 2023 |
2022 | Transcriptional biomarkers for treatment monitoring of pulmonary drug-resistant tuberculosis: Protocol for a prospective observational study in Indonesia | Tropical Medicine and Infectious Disease, 2022, 7(11), 326 |
2022 | Rasch Modelling to Assess Psychometric Validation of the Knowledge about Tuberculosis Questionnaire (KATUB-Q) for the General Population in Indonesia | International Journal of Environmental Research and Public Health, 2022, 19(24), 16753 |
2022 | Multi Epitope-Based Vaccine Design for Protection Against Mycobacterium tuberculosis and SARS-CoV-2 Coinfection | Advances and Applications in Bioinformatics and Chemistry, 2022, 15, pp. 43–57 |
2021 | Omics biomarker for monitoring tuberculosis treatment: A mini review of recent insights and future approaches | Infection and Drug Resistance, 2022, 15, pp. 2703–2711 |
2021 | Docking-based virtual screening and molecular dynamics simulations of quercetin analogs as enoyl-acyl carrier protein reductase (Inha) inhibitors of mycobacterium tuberculosis | Scientia Pharmaceutica, 2021, 89(2),20 |
2020 | Regulation of mitogen-activated protein kinase signaling pathway and proinflammatory cytokines by ursolic acid in murine macrophages infected with Mycobacterium avium | Infectious Disease Reports, 2020, 12, 8717 |
WORK EXPERIENCE
Year | Job Title | Job Description | Organization |
2021-current | Lecturer | Research of interest:
· Biomarker findings in tuberculosis treatment using omics analysis · Develop a digital health system using biomedical data on infectious diseases |
Department of Pharmacology-Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran |
2023 | Visiting research staff | Training on next-generation sequencing using nanopore and downstream analysis using omics data | Bioinformatics Center, Department of Infection Metagenomic, Osaka University, Japan |
2020-2021 | Postdoctoral Fellow | Conducted research on:
· Screening and validation of blood-based signature in tuberculosis treatment · Genotypic-phenotypic correlation of pyrazinamide resistant in multidrug-resistant TB |
Department of Pharmacology-Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran |
2020 | Research analyst | · Conducted regular testing for COVID-19 using real-time PCR
· Performed research on the validation of rapid diagnostic tests for COVID-19 |
Central Laboratory Universitas Padjadjaran |
2018-2019 | Visiting research scientist | Performed research on understanding the regulation of the MAPK signalling pathway by ursolic acid in macrophages infected with Mycobacteria | Department of Respiratory Sciences, University of Leicester, United Kingdom |
COMMUNITY SERVICE EXPERIENCE
Year | Job Title | Program Title | Location |
2023 | Educator | Pharmacamp 2023: Assisted village of tropical fruit from Parakanmanggu for Indonesia | Pangandaran – Indonesia |
2023 | Educator | Education of antibacterial solid soap making based on manggis skin and virgin coconut oil in Parakanmanggu village | Pangandaran – Indonesia |
2022 | Educator | Education of antibiotic resistance in children for parents in Arcamanik District | Bandung – Indonesia |
ORGANIZATION EXPERIENCE
Year | Position | Organization |
2021 – current | Member | Jejaring Riset Tuberculosis (JetSet TB) |
2023 – current | Member | Super Photon ring-8 GeV (SPRING-8) |
2016 – current | Member | Indonesian Pharmacist Association (IAI) |
LANGUAGE
English – Fluent
Japanese – Intermediate